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Neuronal cell death is accompanied by mitochondrial dysfunction with mitochondrial main-
tenance critical to neuronal survival. The mitochondrial ubiquitin ligase MARCH5 has dual
roles in the upkeep of mitochondrial function. MARCH5 is involved in targeted degradation
of proteins harmful to mitochondria and impacts mitochondrial morphology upstream of
the ﬁssion protein Drp1. In a neuronal cell model, dominant-negative MARCH5 prevents
mitochondrial fragmentation during neurodegenerative stress induced by the neuron-
speciﬁc reactive oxygen generator 6-hydroxydopamine, the complex I inhibitor rotenone
or Alzheimer’s-related amyloid beta peptide. In addition, preservation of mitochondrial
function in terms of membrane potential and lower reactive oxygen generation was
observed following inactivation of MARCH5. Our ﬁndings connect MARCH5 to neuronal
stress responses and further emphasize the link between mitochondrial dynamics and
function.
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INTRODUCTION
Mitochondrial dysfunction is at the heart of neurodegeneration
(Karbowski and Neutzner, 2012), since neuronal cells are espe-
cially dependent on high ﬁdelity mitochondria to meet their
extraordinary energy demand. Loss of mitochondrial ﬁdelity
due to accumulation of damage is thought to be one of the
central mechanisms for the death of neuronal cells associated
with virtually all neurodegenerative disorders as well as aging.
Damage to mitochondria is caused mainly through reactive
reaction intermediates of the mitochondrial electron transport
chain (ETC) namely reactive oxygen species (ROS) and reac-
tive nitrogen species (RNS). Main targets of ROS and RNS are
mitochondrial proteins as well as mitochondrial DNA but also
mitochondrial lipids. Especially damage to proteins of the ETC
and to mitochondrial DNA, which codes mainly for ETC com-
ponents, impacts mitochondrial health as a subpar ETC gives
rise to even more reactive intermediates through electron leak-
age. Various repair, salvage, and maintenance mechanisms are
in place to deal with such stresses and to keep mitochondria
in a healthy and functional state. On the level of mitochon-
drial DNA, various repair mechanisms are active, drawing from
the large redundancy of mitochondrial DNA with up to 10,000
copies per cell (Bogenhagen and Clayton, 1974). On the protein
level, removal of damaged proteins takes place via specialized pro-
teases in the matrix and inner mitochondrial membrane (Rugarli
and Langer, 2012) or through the ubiquitin–proteasome system
during outer mitochondrial membrane-associated degradation
(OMMAD; Neutzner et al., 2007). On the organellar level, the
mitochondrial network is maintained through dynamic ﬁssion
and fusion of mitochondrial tubules essential for adaption of
the network to cellular demand (Youle and van der Bliek, 2012).
Furthermore, removal of irreparable mitochondrial subunits by
mitophagy, a specialized autophagic process, is essential for main-
taining organellar ﬁdelity (Youle and Narendra, 2011). Lastly, on
the cellular level, irreparable damage to themitochondrial network
causes the induction of apoptosis, thus constituting a complete
removal of dysfunctional organelles (Tatsuta and Langer, 2008;
Karbowski and Neutzner, 2012). In the case of neuronal tissue
with its very limited capacity for regeneration, induction of the
cell death program is deleterious and results in the irreparable
loss of neuronal function leading ultimately to neurodegenerative
disease.
The mitochondrial ubiquitin ligase MARCH5/MITOL
(Yonashiro et al., 2006; Karbowski et al., 2007) is involved in
maintainingmitochondrial function.MARCH5was shown to reg-
ulatemitochondrialmorphology through regulatingDrp1 activity
(Karbowski et al., 2007), thereby impacting cellular senescence
(Park et al., 2010) and modulating neuronal death (Fang et al.,
2012). Furthermore, MARCH5 was implicated in the regulation
of endoplasmic reticulum (ER)–mitochondrial tethering through
ubiquitination of mitofusinMfn2 (Sugiura et al., 2013). MARCH5
also plays a role in the degradationofmSOD1associatedwith amy-
otrophic lateral sclerosis (Yonashiro et al., 2009), in the disposal of
mutated ataxin-3 causative for Machado–Joseph disease (Sugiura
et al., 2011) as well as the clearance of S-nitrosylated MAP1B-
light chain 1 linked to neuronal degeneration (Yonashiro et al.,
2012).
Here we found MARCH5 to be involved in the mito-
chondrial answer to neurodegenerative stress evoked by 6-
hydroxydopamine (6-OHDA),a superoxide generating compound
selective for neuronal cells, the mitochondrial poison rotenone
or Alzheimer’s-related amyloid beta (Aβ). While MARCH5
increased mitochondrial effects of neurodegenerative stress, inac-
tivation of MARCH5 reversed stress-induced fragmentation and
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strongly ameliorated stress-related mitochondrial dysfunction
pointing to an active role of MARCH5 in stress response
decisions.
RESULTS
Here, treatment of SH-SY5Y neuroblastoma cells with the
dopaminergic and noradrenergic neuron-speciﬁc ROS generator
6-OHDA, the mitochondrial ETC complex I inhibitor rotenone,
or the Aβ peptide was employed to study mitochondrial func-
tion in a model for neuronal cells under neurodegenerative stress.
As revealed by cytochrome c staining, following treatment with
6-OHDA (Figure 1B), rotenone (Figure 1C), or Aβ peptide
(Figure 1D) the mitochondrial network is considerably frag-
mented when compared to control cells (Figure 1A). The extent
of mitochondrial fragmentation was strongest with 6-OHDA,
still strong following rotenone and less pronounced after Aβ
treatment. These data are consistent withmitochondrial fragmen-
tation in neuronal cells in response to neurodegenerative stress
evoked by exogenous ROS, mitochondria-generated ROS as well
as mitochondrial dysfunction due to Aβ, respectively.
FIGURE 1 | Neurodegenerative stress causes mitochondrial
fragmentation in neuronal cells. SH-SY5Y cells mock treated (control) (A)
or exposed for 6 h to 75 μM 6-hydroxydopamine (6-OHDA) (B), for 6 h to
5 μM rotenone (rotenone) (C), or for 24 h to 25 μM Aβ peptide (Aβ) (D)
were ﬁxed and stained using anti-cytochrome c antibodies and DAPI to
reveal mitochondrial morphology and the nucleus, respectively. Shown are
representative pictures of at least three independent experiments.
To study the role of MARCH5 in the mitochondrial
response to neurodegenerative stress in neuronal cells, wildtype
MARCH5, ubiquitin ligase activity negative MARCH5H43W, or
mitochondria-targeted yellow ﬂuorescent protein (mitoYFP) as
control were stably expressed in SH-SY5Y cells. As shown in
Figure 2A and consistent with previous observations in HeLa
cells (Karbowski et al., 2007), expression of MARCH5 in SH-SY5Y
cells had no discernible impact on mitochondrial morphology,
while expression of dominant-negative MARCH5H43W caused
considerable elongation of themitochondrial network when com-
pared to control cells. In addition and as also reported previously
(Karbowski et al., 2007), MARCH5H43W localized to distinct sub-
mitochondrial foci in SH-SY5Y cells while wildtype MARCH5
localized to mitochondria in a circumscribing fashion.
To test whether MARCH5 activity is necessary for neu-
rodegenerative stress-induced mitochondrial fragmentation, cells
stably expressing MARCH5, MARCH5H43W, or mitoYFP were
treated with 6-OHDA (Figure 2B), rotenone (Figure 2C), or Aβ
(Figure 2D) andmitochondrial morphology was observed follow-
ing cytochrome c staining. While mitochondrial fragmentation
was still evident in cells expressing MARCH5 or YFP, expres-
sion of MARCH5H43W in SH-SY5Y cells prevented mitochondrial
fragmentation evoked by neurodegenerative stress conditions.
To quantify the impact of MARCH5H43W on preservation of
mitochondrial morphology in SH-SY5Y cells following neurode-
generative stress, mitochondrial interconnectivity was measured.
To this end, SH-SY5Y cells co-transfected with expression plas-
mids for MARCH5 or MARCH5H43W and mitochondria-targeted
photoactivatable GPF (PA-GFP) were treated with 6-OHDA
(Figure 3A), rotenone (Figure 3B), or Aβ (Figure 3C) or mock
treated as control and diffusion of PA-GFP was measured follow-
ing 405 nm laser activation of a small part of the mitochondrial
network. The area of PA-GFP of the mitochondrial network cov-
ered by activated PA-GFP served as measure for interconnectivity
of individual mitochondrial tubules. Treatment of SH-SY5Y cells
with 6-OHDA in the presence of MARCH5 expression caused
a loss of mitochondrial connectivity compared to mock treated
MARCH5 expressing cells, while treatment with 6-OHDA of
MARCH5H43W expressing cells had no impact on mitochondrial
interconnectivity compared to untreated control cells (Figure 3A).
Using rotenone as inducer of neurodegenerative stress, blocking
MARCH5 function through expression ofMARCH5H43W was also
able to almost completely suppress loss of mitochondrial intercon-
nectivity (Figure 3B). As for treatment of SH-SY5Y cells with Aβ,
MARCH5H43W was able to suppress mitochondrial ﬁssion com-
pared to MARCH5 expressing cells and preserve connectivity of
mitochondrial tubules at levels almost comparable to control cells
(Figure 3C).
To evaluate whether inactivation of MARCH5 has impact not
only on mitochondrial dynamics, but also on mitochondrial
core function under neurodegenerative stress conditions, mito-
chondrial membrane potential in MARCH5 or MARCH5H43W
expressing cells following treatment with 6-OHDA, rotenone or
Aβ was measured (Figure 4) with mock treated cells serving
as control. To this end, cells were loaded with the mitochon-
drial membrane sensitive dye tetramethylrhodamine ethyl ester
(TMRE) and single cell analysis of confocal imageswas performed.
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FIGURE 2 | Inactivation of MARCH5 prevents stress-induced
mitochondrial fragmentation. SH-SY5Y cells selected to express
mitochondria-targeted YFP (mitoYFP), MARCH5-YFP, or MARCH5H43W-YFP
mock treated (A) or treated with 75 μM 6-hydroxydopamine for 6 h (B),
5 μM rotenone for 6 h (C), or 25 μM Aβ peptide for 24 h (D) were
ﬁxed and stained using anti-cytochrome c antibodies and imaged using
confocal microscopy (cytochrome c – red; YFP – green). Shown are
representative pictures of at least three independent experiments.
While expression of MARCH5 had no effect on mitochondrial
membrane potential when compared to mitoYFP expressing con-
trol cells, expression of MARCH5H43W caused mitochondrial
hyperpolarization (Figure 4A). Treatment of MARCH5 express-
ing cells with 6-OHDA (Figure 4B), rotenone (Figure 4C), or Aβ
(Figure 4D) caused signiﬁcant loss of mitochondrial membrane
potential in comparison to untreated MARCH5 expressing cells.
Also, treating MARCH5H43W expressing cells with these stressors
resulted in a loss of mitochondrial membrane potential com-
pared to untreated MARCH5H43W control cells. However, loss
of membrane potential was less pronounced in MARCH5H43W
expressing cells between stressed and unstressed conditions
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FIGURE 3 | Inactive MARCH5 supports mitochondrial interconnectivity
under neurodegenerative stress conditions. SH-SY5Y co-transfected with
expression plasmids for PA-GFP and either MARCH5 or MARCH5H43W were
treated with 75 μM 6-hydroxydopamine for 6 h (A), 5 μM rotenone for 6 h
(B), or 25 μM Aβ peptide for 24 h (C) and mitochondrial interconnectivity was
measured following activation of PA-GFP in a small area of the mitochondrial
network. Shown is one representative picture and the average of three
independent experiments with 15 cells each/condition. Statistical signiﬁcance
was analyzed using Student’s t -test with ** marking p < 0.01. Error bars
represent SEM.
compared to wildtype MARCH5 expressing cells. Comparing
MARCH5 and MARCH5H43W expressing cells, the membrane
potential in stressed MARCH5H43W cells is at levels seen in
unstressed MARCH5 expressing cells.
To further gain insight into the mechanisms responsible
for MARCH5H43W-mediated protection from neurodegenerative
stress, cellular levels of ROS were assessed using single cell analysis
of CellRox ﬂuorescence. To this end, ﬁrst, ROS levels were mea-
sured in cells expressing MARCH5, MARCH5H43W or mitoYFP
and no signiﬁcant difference between either group was detected
(Figure 5A). Analysis of MARCH5 or MARCH5H43W expressing
cells treated with 6-OHDA revealed an increase in intracellular
ROS in MARCH5 cells, while expression of MARCH5H43W pre-
vented this 6-OHDA-mediated spike in ROS almost completely
(Figure 5B). Similarly, expression of MARCH5H43W was able to
blunt ROS production following treatment with rotenone, while
ROS levels were elevated about twofold in MARCH5 expressing
cells compared to untreated MARCH5 expressing control cells
(Figure 5C). As for mitochondrial stress evoked by treatment with
Aβ, ROS levels in MARCH5H43W expressing cells were about 50%
compared to cells producing MARCH5. However, Aβ treatment
caused still an increase in ROS even in the presence of inactive
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FIGURE 4 | Mitochondrial membrane potential under
neurodegenerative stress conditions is increased following
inactivation of MARCH5. (A) SH-SY5Y cells expressing mitoYFP,
MARCH5-YFP, or MARCH5H43W-YFP were stained with the mitochondrial
membrane potential sensitive dyeTMRE, images were taken by confocal
microscopy andTMRE ﬂuorescence as measure for mitochondrial
membrane potential was determined using image analysis. SH-SY5Y cells
expressing MARCH5-YFP or MARCH5H43W-YFP were treated with 75 μM
6-hydroxydopamine for 6 h (B), 5 μM rotenone for 6 h (C), or 25 μM Aβ
peptide for 24 h (D) and mitochondrial membrane potential was measured
as in (A). Shown is the average of three independent experiments with 10
cells each per condition. Statistical signiﬁcance was analyzed using
Student’s t -test with * p<0.05; n.s. p>0.05, not signiﬁcant and ** marking
p < 0.01. Error bars represent SEM.




Human neuroblastoma cell line SH-SY5Y was purchased from
DSMZ. SH-SY5Y cells were cultured in high glucose Dulbecco’s
modiﬁed Eagle’s medium (DMEM), supplemented with 2 mM L-
glutamine, 1 mM sodium pyruvate, and 15% fetal bovine serum
(Sigma). Cells were incubated in a humidiﬁed incubator at 5%
CO2 and 37◦C.
SH-SY5Y cells were transfected using Effectene (Qiagen)
according to the manufacturer’s recommendations. To generate
stably expressing SH-SY5Y cells, selection was performed using
geneticin sulfate (400 μg/ml) for 4 weeks. Degree of transfection
was established using ﬂow cytometric analysis (CyAn ADP, Beck-
man Coulter) and found to be around 80%. SH-SY5Y cells were
treated with 6-OHDA (75 μM, 6 h), rotenone (5 μM, 6 h), and
Aβ-peptide 25–35 (Sigma A4559, 25 μM, 24 h).
MICROSCOPY
For immunocytochemistry, cells were seeded in six-well plates
onto glass slides at 1 × 104 cells/well in 2 ml culture medium.
Sampleswereﬁxedusingmethanol-free electronmicroscopy grade
4% paraformaldehyde in phosphate buffered saline (PBS) for
15 min at room temperature (RT), permeabilized for 15 min at
RT using 0.15% Trixon X-100 in PBS and blocked for 1 h in
10% bovine serum albumin (BSA) in PBS. To visualize mitochon-
dria, samples were then incubated with mouse anti-cytochrome c
antibody (BD Biosciences 556432, 1:1000) overnight at 4◦C and
Alexa546-conjugated anti-mouse antibodies (Invitrogen A11003,
1:500) for 1 h at RT. Samples were mounted in mounting medium
(Vectashield H1000) and observed using a confocal microscope
(Zeiss LSM Meta710, 63×/1.4 objective). For life cell imaging,
cells were seeded onto chambered coverglass (Nunc Lab-Tek,
154461) at a density of 5 × 103/well in 1 ml culture media. Mea-
surement of mitochondrial interconnectivity was performed as
described before (Fang et al., 2012). In short, SH-SY5Y cells were
transfected with an expression construct for PA-GFP and mito-
chondrial network area following photoconversion of PA-GFP
employing a 405-nm laser was measured. To measure mitochon-
drial membrane potential, cells were stained with 100 nM TMRE
(Invitrogen, T-669) in media for 20 min at 37◦C and washed
three times with media. Imaging was performed on a LSM710
confocal microscope (Zeiss) equipped with a live cell imaging
chamber. Z-stacks (ﬁve images, 1 μm distance) were acquired
and image analysis was performed using Imaris v7.0 software
(Bitplane Scientiﬁc Software). Data are expressed as mean sig-
nal intensity of 30 randomly selected cells per treatment group
(three independent experiments, 10 cells each). To measure cellu-
lar ROS, cells were stained using 5μMCellROXDeep Red Reagent
(Invitrogen, C10422) for 30 min at 37◦C, washed three times
with PBS and ﬁxed using 4% paraformaldehyde before imag-
ing. Z-stacks (ﬁve images at 1 μm intervals) were acquired and
analyzed using Imaris 7.0. Data are expressed asmean signal inten-
sity of cells (four independent experiments, 10 cells each/group
each).
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FIGURE 5 | Inactivation of MARCH5 blunts ROS production under
neurodegenerative stress conditions. (A) SH-SY5Y cells expressing
mitoYFP, MARCH5-YFP, or MARCH5H43W-YFP were treated with the
ROS-sensitive dye CellROX and intracellular ROS levels were measured
using image analysis of confocal pictures. SH-SY5Y cells expressing
MARCH5-YFP or MARCH5H43W-YFP were treated with 75 μM
6-hydroxydopamine for 6 h (B), 5 μM rotenone for 6 h (C), or 25 μM Aβ
peptide for 24 h (D) and mitochondrial membrane potential was measured
as in (A). Shown is the average of four independent experiments with 10
cells per condition. Statistical signiﬁcance was analyzed using Student’s
t -test with ** marking p < 0.01 and n.s. marking no signiﬁcant difference.
Error bars represent SEM.
STATISTICAL ANALYSIS
Statistical analysis was performed using unpaired, two-tailed Stu-
dent’s t-test as implemented inMicrosoft Excel. A p-value of<0.05
or smaller was considered statistically signiﬁcant and is marked
with *, while p-values of <0.01 are marked with **. Error bars
represent the standard error of the mean (SEM).
DISCUSSION
While MARCH5 is involved in the removal of proteins associ-
ated with speciﬁc neurodegenerative disorders such as ataxin-3
in Machado–Joseph disease or mSOD1 in amyotrophic lateral
sclerosis likely supporting mitochondrial function, MARCH5
activity during general mitochondrial oxidative stress does not
seem to confer a protective effect. Mitochondrial fragmentation
in response to oxidative insults evoked by external ROS genera-
tors such as 6-OHDA or internal ROS generators such as rotenone
or Aβ was greatly diminished in cells expressing MARCH5H43W,
while wildtype MARCH5 did not prevent the remodeling of the
mitochondrial network in response to stress. Thus it is conceiv-
able that during neurodegenerative stress, removal of damaged
proteins from mitochondria through MARCH5 seems not to be
as essential as one might expect from an ubiquitin ligase involved
in mitochondrial protein quality control. Rather, the function of
MARCH5 as mitochondrial morphogen modulating Drp1 activ-
ity might be important in this context. And indeed we previously
showed that inactivation of MARCH5protects neuronal cells from
stress-induced cell death (Fang et al., 2012) likely through the
inhibition of Drp1-dependent mitochondrial fragmentation in
accordance with previous observations where inhibition of Drp1
activity strongly delayed cell death (Frank et al., 2001). Thus, the
function of MARCH5 in regulating mitochondrial morphology
might also be the main factor in the here observed positive effect
on mitochondrial ﬁdelity upon expression of dominant-negative
MARCH5H43W. Fragmentation of the mitochondrial network is a
response to potentially lethal stress conditions such as increased
oxidative stress or loss of membrane potential. As mitochon-
drial fragmentation is an integral part of the apoptotic program
with forced fragmentation sensitizing cells to apoptotic stim-
uli (Lee et al., 2004), shortening mitochondria does not seem
to have a protective effect on cells but might rather be seen as
preparation for starting the cell death program although mito-
chondrial ﬁssion per se is not an apoptotic stimulus (Youle and
van der Bliek, 2012). In contrast, elongation of mitochondria
seems to be protective as evidenced by de-sensitization to apop-
totic stimuli following increased mitochondrial fusion (Neuspiel
et al., 2005). Also during stress-induced mitochondrial hyperfu-
sion (SIMH),enhanced fusion and therefore highly interconnected
mitochondrial tubules prove to increase resistance against cer-
tain stresses (Tondera et al., 2009). While most experimental
stress conditions induce mitochondrial fragmentation, stress at
levels well below the apoptotic threshold induces mitochondrial
elongation. The SIMH-associated adaptionofmitochondrialmor-
phology is brought about in an Mfn1- and OPA1-dependent but
Mfn2-independent manner and is likely not achieved by forced
mitochondrial elongation due to inhibition of Drp1 function
(Tondera et al., 2009). The increased interconnectivity during
SIMH conditions mitochondria against further stress potentially
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by boosting their ATP production likely via increased avail-
ability of substrates and ETC intermediates in fused mito-
chondrial reticulum with its extended matrix space. Whether
inactivation of MARCH5 induces SIMH is unclear as mitochon-
drial elongation in the absence of external stress is evident in
MARCH5H43W expressing cells, however, the observed increase
of mitochondrial membrane potential in unstressed cells and
the blunting of stress-induced ROS production point in this
direction. This leaves the question, which additional pathways
besides inhibition of Drp1-mediated ﬁssion might be inﬂuenced
by MARCH5H43W as simply inhibiting Drp1 does not seem to
evoke SIMH (Tondera et al., 2009). Based on our results, one
might speculate that MARCH5 as upstream regulator of Drp1
is important during cellular stress responses and might mod-
ulate the activity of other targets besides Drp1. The notion
of MARCH5 regulating other such targets is supported by our
observation that expression of wildtype MARCH5 did not pre-
serve mitochondrial function under neurodegenerative stress
conditions although no effect on mitochondrial interconnectiv-
ity was observed (Karbowski et al., 2007). Importantly, expression
of MARCH5 in the absence of stress conditions did not impact
mitochondrial membrane potential or ROS production further
hinting to a role for MARCH5 during mitochondrial stress.
Thus, based on our observations following dominant-negative
MARCH5H43W expression and the effects of wildtype MARCH5,
it seems conceivable that MARCH5 is involved in the decision
for stress-induced fragmentation versus protective mitochon-
drial elongation. Taken together, our data further support a
role of MARCH5 in the modulation of Drp1 activity during
mitochondrial ﬁssion and implicate MARCH5 in mitochondrial
stress response pathways. As the mitochondrial stress response is
pathophysiologically signiﬁcant from diabetes to cardiovascular
disease to neurodegeneration, blockage of MARCH5 might be an
interesting therapeutic strategy.
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